News & Resources

Drug Studies’ Results Make Case for Access to All Opioid Dependence Medications

Dr. Joseph Garbely, D.O., FASAM, Vice President of Medical Services and Medical Director, Caron Treatment Centers, is reassured by results of two recent studies, that showed comparable efficacy and safety between sublingual buprenorphine and injectable naltrexone for opioid dependence.

See story in Addiction Professional

We're one call away.

We're here 24-7

Chat now.

When you're ready...

Fill out a form.